Skip to main content
logo
Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
14.43
-0.26 (-1.77%)
May 7, 2026, 9:52 AM EDT - Market open

TNXP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2052001452430177
Market Cap Growth
112.94%38.09%512.36%-20.74%-83.20%27.94%
Enterprise Value
2.35-6.753.728.22-90.1-0.77
Last Close Price
14.4315.6232.981289.607796.00228928.00
PE Ratio
--1.07-0.19-0.09-0.12-1.41
PS Ratio
15.9215.2414.333.04--
PB Ratio
0.770.811.040.220.140.81
P/TBV Ratio
0.500.540.170.100.070.60
P/FCF Ratio
--1.94-2.37-0.21-0.20-1.60
P/OCF Ratio
--2.00-2.37-0.23-0.30-2.35
EV/Sales Ratio
0.18-0.515.321.06--
EV/EBITDA Ratio
-0.05-0.40-0.070.810.01
EV/EBIT Ratio
-0.05-0.39-0.070.800.01
EV/FCF Ratio
-0.06-0.88-0.070.620.01
Debt / Equity Ratio
0.000.000.060.090.000.00
Debt / EBITDA Ratio
-0.01-0.01-0.06-0.09-0.01-0.01
Debt / FCF Ratio
-0.01-0.01-0.13-0.090.00-0.01
Net Debt / Equity Ratio
-0.84-0.84-0.65-0.14-0.58-0.81
Net Debt / EBITDA Ratio
1.671.670.680.131.081.93
Net Debt / FCF Ratio
2.002.001.490.140.821.60
Asset Turnover
0.060.060.060.0400
Inventory Turnover
0.920.920.700.70--
Quick Ratio
6.946.945.601.326.618.23
Current Ratio
7.137.136.062.537.198.71
Return on Equity (ROE)
-64.46%-64.48%-106.12%-74.61%-51.76%-60.25%
Return on Assets (ROA)
-57.13%-57.13%-86.15%-62.28%-48.05%-54.45%
Return on Invested Capital (ROIC)
-286.59%-286.59%-168.62%-117.82%-174.15%-348.98%
Return on Capital Employed (ROCE)
-64.31%-64.31%-97.59%-69.01%-52.54%-60.03%
Earnings Yield
-59.43%-93.28%-535.48%-1141.46%-821.34%-70.76%
FCF Yield
-49.46%-51.67%-42.20%-465.24%-490.54%-62.49%
Buyback Yield / Dilution
-1055.90%-1055.90%-9191.34%-334.14%-220.61%-285.23%
Total Shareholder Return
-1055.90%-1055.90%-9191.34%-334.14%-220.61%-285.23%
Updated Mar 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q